Picture of Acarix AB logo

ACARIX — Acarix AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Acarix - Positive Results From Acarix Study Presented At Ispor

Nov 18 (Reuters) - Acarix AB  ACARIX.ST :
    * POSITIVE RESULTS FROM ACARIX STUDY PRESENTED AT ISPOR, A LEADING HEALTH ECONOMICS
CONFERENCE
    * ACARIX AB - IN CLINICAL TRIALS, ULTRA-SENSITIVE PHONOCARDIOGRAPHY HAS PROVEN TO BE A
CLINICALLY
RELEVANT DIAGNOSTIC MEASUREMENT
    * ACARIX AB - STUDY COMPARED TWO PATIENT SETS, 1030 PATIENTS FROM GERMANY AND AUSTRIA AND
1501
FROM DANNICAD-1 TRIAL IN DENMARK
    * ACARIX AB - CONCLUSION REACHED IS THAT "IN CLINICAL TRIALS, ULTRA-SENSITIVE
PHONOCARDIOGRAPHY
HAS PROVEN TO BE A CLINICALLY RELEVANT DIAGNOSTIC MEASUREMENT

Source text for Eikon:  ID:nGNE33MWf7 
Further company coverage:  ACARIX.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Acarix AB

See all news